Connection

Peter Verhamme to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Drug Therapy, Combination.
Peter Verhamme
Connection Strength
0.055
Drug Therapy, Combination
  1. A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020 Dec 09; 21(1):1005.
    View in: PubMed
    Score: 0.020
  2. Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis. Circulation. 2019 10 29; 140(18):1451-1459.
    View in: PubMed
    Score: 0.018
  3. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. J Am Coll Cardiol. 2018 05 22; 71(20):2306-2315.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.